MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
3.760
-0.010 (-0.27%)
At close: Nov 4, 2024, 4:00 PM
3.650
-0.110 (-2.93%)
Pre-market: Nov 5, 2024, 8:16 AM EST
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $393.04 million as of November 5, 2024. Its market cap has increased by 21.72% in one year.
Market Cap
393.04M
Enterprise Value
250.76M
1-Year Change
21.72%
Ranking
Category
Stock Price
$3.76
Market Cap Chart
Since the IPO on July 30, 2021, MaxCyte's market cap has decreased from $897.06M to $393.04M, a decrease of -56.19%. That is a compound annual growth rate of -22.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 395.10M | -18.84% |
| Dec 29, 2023 | 486.80M | -12.63% |
| Dec 30, 2022 | 557.20M | -45.55% |
| Dec 31, 2021 | 1.02B | 14.08% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Esperion Therapeutics | 398.34M |
| C4 Therapeutics | 396.00M |
| enGene Holdings | 393.08M |
| Sangamo Therapeutics | 391.45M |
| ZimVie | 387.49M |
| ProQR Therapeutics | 384.95M |
| Amylyx Pharmaceuticals | 383.99M |
| Cross Country Healthcare | 383.05M |